BACKGROUND: Donor glomerulosclerosis, interstitial fibrosis, and fibrous intimal thickening correlate with graft outcome. We evaluate chronic lesions in donor biopsies according to Banff criteria and with a morphometric technique to ascertain their predictive value on graft outcome. METHODS: We evaluated 77 cadaveric donor biopsies according to Banff criteria. Glomerulosclerosis was expressed as the percentage of global sclerotic glomeruli. The following morphometric parameters were obtained: cortical interstitial volume fraction (Vvint/c), cortical glomerular volume fraction (Vvglom/c), mean glomerular volume (Vg), mean and maximal intimal arterial volume fraction (Vvintima/art), and Vvintima/art of the largest artery. We evaluated the correlation of histologic lesions with delayed graft function, 3 months' glomerular filtration rate (GFR), and death-censored graft survival. RESULTS: Multivariate logistic regression showed that delayed graft function was associated with cv score [relative risk (RR) 4.2 and 95% CI 1.1 to 16.0) and glomerulosclerosis (RR 1.06 and 95% CI 1.01 to 1.13). Stepwise regression showed that Vvint/c and glomerulosclerosis were independent predictors of 3 months' GFR (R= 0.62, P= 0.0001). Repeated analysis not considering morphometric parameters showed that glomerulosclerosis, cv score and ci score were independent predictors of 3 months' GFR (R= 0.64, P= 0.0001). A donor chronic damage score was generated considering glomerulosclerosis, cv score and ci score. This score after adjusting for clinical variables was associated with 3 months' GFR (R= 0.71, P < 0.0001) and death-censored graft survival (RR 2.2 and 95% CI 1.3 to 3.7). CONCLUSION: Combined evaluation of donor glomerulosclerosis, chronic vascular and interstitial damage according to Banff criteria allows a precise prediction of graft outcome. Morphometric evaluation of donor biopsies does not improve the predictive value of semiquantitative grading.
BACKGROUND:Donorglomerulosclerosis, interstitial fibrosis, and fibrous intimal thickening correlate with graft outcome. We evaluate chronic lesions in donor biopsies according to Banff criteria and with a morphometric technique to ascertain their predictive value on graft outcome. METHODS: We evaluated 77 cadaveric donor biopsies according to Banff criteria. Glomerulosclerosis was expressed as the percentage of global sclerotic glomeruli. The following morphometric parameters were obtained: cortical interstitial volume fraction (Vvint/c), cortical glomerular volume fraction (Vvglom/c), mean glomerular volume (Vg), mean and maximal intimal arterial volume fraction (Vvintima/art), and Vvintima/art of the largest artery. We evaluated the correlation of histologic lesions with delayed graft function, 3 months' glomerular filtration rate (GFR), and death-censored graft survival. RESULTS: Multivariate logistic regression showed that delayed graft function was associated with cv score [relative risk (RR) 4.2 and 95% CI 1.1 to 16.0) and glomerulosclerosis (RR 1.06 and 95% CI 1.01 to 1.13). Stepwise regression showed that Vvint/c and glomerulosclerosis were independent predictors of 3 months' GFR (R= 0.62, P= 0.0001). Repeated analysis not considering morphometric parameters showed that glomerulosclerosis, cv score and ci score were independent predictors of 3 months' GFR (R= 0.64, P= 0.0001). A donor chronic damage score was generated considering glomerulosclerosis, cv score and ci score. This score after adjusting for clinical variables was associated with 3 months' GFR (R= 0.71, P < 0.0001) and death-censored graft survival (RR 2.2 and 95% CI 1.3 to 3.7). CONCLUSION: Combined evaluation of donorglomerulosclerosis, chronic vascular and interstitial damage according to Banff criteria allows a precise prediction of graft outcome. Morphometric evaluation of donor biopsies does not improve the predictive value of semiquantitative grading.
Authors: Aleksandar Denic; Martha C Morales; Walter D Park; Byron H Smith; Walter K Kremers; Mariam P Alexander; Fernando G Cosio; Andrew D Rule; Mark D Stegall Journal: Am J Transplant Date: 2019-05-06 Impact factor: 8.086
Authors: Anja Gallinat; Andreas Paul; Thomas Minor; Jürgen W Treckmann; Ernesto P Molmenti; Oliver Witzke; Georgios C Sotiropoulos Journal: Int Urol Nephrol Date: 2012-07-01 Impact factor: 2.370
Authors: Krista L Lentine; Vidya A Fleetwood; Yasar Caliskan; Henry Randall; Jason R Wellen; Melissa Lichtenberger; Craig Dedert; Richard Rothweiler; Gary Marklin; Diane Brockmeier; Mark A Schnitzler; Syed A Husain; Sumit Mohan; Bertram L Kasiske; Matthew Cooper; Roslyn B Mannon; David A Axelrod Journal: Kidney Int Rep Date: 2022-03-28
Authors: Syed Sikandar Raza; Gaurav Agarwal; Douglas Anderson; Mark Deierhoi; Huma Fatima; Michael Hanaway; Jayme Locke; Paul MacLennan; Babak Orandi; Carlton Young; Roslyn B Mannon; Michael E Seifert Journal: Clin Transplant Date: 2022-04-26 Impact factor: 3.456
Authors: Bertram L Kasiske; Darren E Stewart; Bipin R Bista; Nicholas Salkowski; Jon J Snyder; Ajay K Israni; Gretchen S Crary; John D Rosendale; Arthur J Matas; Francis L Delmonico Journal: Clin J Am Soc Nephrol Date: 2014-02-20 Impact factor: 8.237
Authors: S Ali Husain; Kristen L King; Ibrahim Batal; Geoffrey K Dube; Isaac E Hall; Corey Brennan; M Barry Stokes; R John Crew; Dustin Carpenter; Hector Alvarado Verduzco; Raphael Rosen; Shana Coley; Eric Campenot; Dominick Santoriello; Adler Perotte; Karthik Natarajan; Vivette D D'Agati; David J Cohen; Lloyd E Ratner; Glen Markowitz; Sumit Mohan Journal: Clin J Am Soc Nephrol Date: 2020-01-23 Impact factor: 8.237